Constructing biomimetic liver models through biomaterials and vasculature engineering
Source abstract
Abstract
Abstract The occurrence of various liver diseases can lead to organ failure of the liver, which is one of the leading causes of mortality worldwide. Liver tissue engineering see the potential for replacing liver transplantation and drug toxicity studies facing donor shortages. The basic elements in liver tissue engineering are cells and biomaterials. Both mature hepatocytes and differentiated stem cells can be used as the main source of cells to construct spheroids and organoids, achieving improved cell function. To mimic the extracellular matrix (ECM) environment, biomaterials need to be biocompatible and bioactive, which also help support cell proliferation and differentiation and allow ECM deposition and vascularized structures formation. In addition, advanced manufacturing approaches are required to construct the extracellular microenvironment, and it has been proved that the structured three-dimensional culture system can help to improve the activity of hepatocytes and the characterization of specific proteins. In summary, we review biomaterials for liver tissue engineering, including natural hydrogels and synthetic polymers, and advanced processing techniques for building vascularized microenvironments, including bioassembly, bioprinting and microfluidic methods. We then summarize the application fields including transplant and regeneration, disease models and drug cytotoxicity analysis. In the end, we put the challenges and prospects of vascularized liver tissue engineering.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Additive Manufacturing and 3D Printing Technologies · Anatomy and Medical Technology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Fluid Power and Mechatronic Systems, Zhejiang University , Hangzhou 310058, China
School of Mechanical Engineering, Zhejiang University , Hangzhou 310058, China
The Affiliated Stomatologic Hospital, School of Medicine, Zhejiang University , Hangzhou 310003, China
School of Materials Science and Engineering, Tongji University , Shanghai 201804, China
Department of Engineering, University of Cambridge , Cambridge CB2 1PZ, UK
References (100+)
Show source-provided references
1. Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells10.1016/S1471-4906(01)01957-3 ↗
2. The global burden of liver disease: the major impact of China10.1002/hep.27406 ↗
3. Recent advances in the development of in vitro liver models for hepatotoxicity testing10.1007/s42242-021-00142-7 ↗
4. Engineering in vitro human tissue models through bio-design and manufacturing10.1007/s42242-020-00080-w ↗
5. Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment10.1016/j.biomaterials.2022.121575 ↗
6. Human biomimetic liver microphysiology systems in drug development and precision medicine10.1038/s41575-020-00386-1 ↗
7. 3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling10.1016/j.addr.2018.06.011 ↗
8. Microchannels in development, survival, and vascularisation of tissue analogues for regenerative medicine10.1016/j.tibtech.2019.04.004 ↗
9. Vascularized and functional human liver from an iPSC-derived organ bud transplant10.1038/nature12271 ↗
10. Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant10.1038/nprot.2014.020 ↗
11. 3D bioprinting for cell culture and tissue fabrication10.1007/s42242-018-0006-1 ↗
12. Vascularization and angiogenesis in tissue engineering: beyond creating static networks10.1016/j.tibtech.2016.03.002 ↗
13. Vascularizing the brain in vitro10.1016/j.isci.2022.104110 ↗
14. Bioprinted 3D vascularized tissue model for drug toxicity analysis10.1063/1.4994708 ↗
15. Extracellular matrix requirements for gastrointestinal organoid cultures10.1016/j.biomaterials.2021.121020 ↗
16. The extracellular matrix as a key regulator of intracellular signalling networks10.1111/bph.14195 ↗
17. The hepatic extracellular matrix. I. Components and distribution in normal liver10.1007/BF01606425 ↗
18. Recent progress in extrusion 3D bioprinting of hydrogel biomaterials for tissue regeneration: a comprehensive review with focus on advanced fabrication techniques10.1039/D0BM00973C ↗
19. Biomaterials for liver tissue engineering10.1007/s12072-013-9503-7 ↗
20. Biochemical basis of hepatocellular injury10.1177/019262339602400111 ↗
21. Extracellular matrix as a driver of progressive fibrosis10.1172/JCI93557 ↗
22. A perspective on 3D bioprinting in tissue regeneration10.1007/s42242-018-0020-3 ↗
23. Concise review: bioprinting of stem cells for transplantable tissue fabrication10.1002/sctm.17-0148 ↗
24. 3D bioprinting using stem cells10.1038/pr.2017.252 ↗
25. Microphysiological systems meet hiPSC technology—new tools for disease modeling of liver infections in basic research and drug development10.1016/j.addr.2018.06.008 ↗
26. Novel hybrid three-dimensional artificial liver using human induced pluripotent stem cells and a rat decellularized liver scaffold10.1016/j.reth.2019.03.002 ↗
27. Porous hydrogel arrays for hepatoma cell spheroid formation and drug resistance investigation10.1007/s42242-021-00141-8 ↗
28. A 3D cell printing-fabricated HepG2 liver spheroid model for high-content in situ quantification of drug-induced liver toxicity10.1039/D1BM00749A ↗
29. Generation of multilayered 3D structures of HepG2 cells using a bio-printing technique10.5009/gnl16010 ↗
30. Customizable microfluidic origami liver-on-a-chip (oLOC)10.1002/admt.202100677 ↗
31. Bioprinting Perfusion-enabled liver equivalents for advanced organ-on-a-chip applications10.3390/genes9040176 ↗
32. Systems biology in hepatology: approaches and applications10.1038/s41575-018-0007-8 ↗
33. The microcirculatory hepatic unit10.1016/0026-2862(73)90021-6 ↗
34. Recent advances in knowledge of the liver10.1152/physrev.1942.22.1.54 ↗
35. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules
36. Liver extracellular matrix in health and disease10.1002/path.1397 ↗
37. The hepatic microvascular system in health and its response to toxicants10.1002/ar.20663 ↗
38. Liver microvascular architecture: an insight into the pathophysiology of portal hypertension10.1055/s-2007-1007126 ↗
39. The unit-concept of hepatic parenchyma—a re-examination based on angioarchitectural studies
40. Liver zonation: novel aspects of its regulation and its impact on homeostasis10.3748/wjg.v20.i26.8491 ↗
41. Morphological mechanisms for regulating blood flow through hepatic sinusoids10.1034/j.1600-0676.2000.020001003.x ↗
42. Hepatic sinusoids versus Central veins: structures, markers, angiocrines, and roles in liver regeneration and homeostasis10.1002/ar.24560 ↗
43. Liver sinusoids: pathology of endothelial findings10.1007/s00292-020-00802-y ↗
44. Pathology of the liver sinusoids10.1111/his.12364 ↗
45. Regulatory mechanisms of hepatic microcirculation
46. Adhesion between cells and extracellular matrix with special reference to hepatic stellate cell adhesion to three-dimensional collagen fibers10.1247/csf.25.329 ↗
47. Subdivision of hexagonal liver lobules into a structural and functional unit. Bole in hepatic physiology and pathology10.1002/ar.1091190103 ↗
48. Liver zonation—revisiting old questions with new technologies10.3389/fphys.2021.732929 ↗
49. Spatial heterogeneity in the mammalian liver10.1038/s41575-019-0134-x ↗
50. Liver zonation, revisited10.1002/hep.32408 ↗
51. Metabolic zonation of the liver: the oxygen gradient revisited10.1016/j.redox.2017.01.012 ↗
52. Metabolic heterogeneity of hepatocytes across the liver acinus10.1093/jn/122.suppl_3.843 ↗
53. Hepatic enzymic zonation: a reevaluation of the concept of the liver acinus10.1002/hep.1840100115 ↗
54. Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences10.1016/j.biochi.2013.06.007 ↗
55. Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 310.1046/j.1440-1746.2001.02445.x ↗
56. The portal lobule in rat liver fibrosis: a re-evaluation of the liver unit10.1002/hep.510270223 ↗
57. Extracellular matrix remodeling in 3D: implications in tissue homeostasis and disease progression10.1002/wnan.1503 ↗
58. Immunomodulatory role of the extracellular matrix within the liver disease microenvironment10.3389/fimmu.2020.574276 ↗
59. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins10.1055/s-2008-1040452 ↗
60. Collagen types in normal and cirrhotic liver10.1016/S0016-5085(79)80170-5 ↗
61. Liver fibrosis10.1172/JCI24282 ↗
62. Advances in the clinical use of collagen as biomarker of liver fibrosis10.1080/14737159.2020.1814746 ↗
63. Extracellular matrix molecular remodeling in human liver fibrosis evolution10.1371/journal.pone.0151736 ↗
64. Notch-triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase10.1002/hep.32332 ↗
65. Engineering liver microtissues for disease modeling and regenerative medicine10.1002/adfm.201909553 ↗
66. Reproducing human and cross-species drug toxicities using a Liver-Chip10.1126/scitranslmed.aax5516 ↗
67. Dual-core coaxial bioprinting of double-channel constructs with a potential for perfusion and interaction of cells10.1088/1758-5090/ac6e88 ↗
68. Establishing a 3D in vitro hepatic model mimicking physiologically relevant to in vivo state10.3390/cells10051268 ↗
69. Three-dimensional fabrication of thick and densely populated soft constructs with complex and actively perfused channel network10.1016/j.actbio.2017.10.047 ↗
70. Pre-set extrusion bioprinting for multiscale heterogeneous tissue structure fabrication10.1088/1758-5090/aac70b ↗
71. 3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression10.1016/j.actbio.2017.12.042 ↗
72. Upgrading hepatic differentiation and functions on 3D printed silk-decellularized liver hybrid scaffolds10.1021/acsbiomaterials.1c00671 ↗
73. Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure10.1136/gutjnl-2019-319960 ↗
74. Efficient fabrication of monodisperse hepatocyte spheroids and encapsulation in hybrid hydrogel with controllable extracellular matrix effect10.1088/1758-5090/ac2b89 ↗
75. Ectopic expansion and vascularization of engineered hepatic tissue based on heparinized acellular liver matrix and mesenchymal stromal cell spheroids10.1016/j.actbio.2021.10.017 ↗
76. Spheroid-cultured human umbilical cord-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury in rats10.1038/s41598-018-20975-0 ↗
77. Synergistic effect of three-dimensional coculture and photobiomodulation therapy on vascularized liver spheroid formation by stem cells10.1002/jcp.30270 ↗
78. Development and application of 3D bioprinted scaffolds supporting induced pluripotent stem cells10.1155/2021/4910816 ↗
79. 3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro10.1088/1758-5090/ab4a30 ↗
80. Stem Cell-Based therapies for liver diseases: an overview and update10.1007/s13770-019-00178-y ↗
81. In vitro human liver model of nonalcoholic steatohepatitis by coculturing hepatocytes, endothelial cells, and kupffer cells10.1002/adhm.201901379 ↗
82. 3D culture of HepaRG cells in GelMa and its application to bioprinting of a multicellular hepatic model10.1016/j.biomaterials.2020.120611 ↗
83. A human liver-on-a-Chip platform for modeling nonalcoholic fatty liver disease10.1002/adbi.201900104 ↗
84. Complex bile duct network formation within liver decellularized extracellular matrix hydrogels10.1038/s41598-018-30433-6 ↗
85. Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing10.1088/1758-5090/aba0c3 ↗
86. Maintenance of primary hepatocyte functions in vitro by inhibiting mechanical Tension-Induced Yap activation10.1016/j.celrep.2019.10.128 ↗
87. Hepatocyte polarity: constitutive and functional characteristics and pathological appearance in liver diseases
88. Bioprinted 3D primary liver tissues allow assessment of organ-level response to clinical drug induced toxicity in vitro10.1371/journal.pone.0158674 ↗
89. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME10.1007/s00204-013-1078-5 ↗
90. Mesenchymal stem cell-derived hepatocytes for functional liver replacement10.3389/fimmu.2012.00168 ↗
91. Liver sinusoidal endothelial cells10.1002/cphy.c140078 ↗
92. Immune function of nonparenchymal liver cells10.4238/gmr.15018524 ↗
93. Liver sinusoidal endothelial cells—gatekeepers of hepatic immunity10.1038/s41575-018-0020-y ↗
94. The role of liver sinusoidal endothelial cells in cancer liver metastasis
95. Structure and function of sinusoidal lining cells in the liver10.1177/019262339602400114 ↗
96. Physiological function and pathological mechanisms of liver sinusoidal endothelial cell
97. The Central role of sinusoidal endothelial cells in hepatic hypoxia-reoxygenation injury in the rat10.1002/hep.510240541 ↗
98. Liver sinusoidal endothelial cells and liver regeneration10.1172/JCI66025 ↗
99. Liver sinusoidal endothelial cell progenitor cells promote liver regeneration in rats10.1172/JCI58789 ↗
100. Current advances on 3D-bioprinted liver tissue models10.1002/adhm.202001517 ↗